Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ENLIE Pharmaceutical JSCHSTC:BCP 25 FCF Yield % is 0.00 as of Jul. 27, 2026. GuruFocus rates HSTC:BCP with a GF Score™ of 25/100. Among 1,006 Drug Manufacturers companies, ENLIE Pharmaceutical JSC ranks worse than 99403.48% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for ENLIE Pharmaceutical JSC's FCF Yield % or its related term are showing as below:
HSTC:BCP's FCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.745 * Ranked among companies with meaningful FCF Yield % only.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
ENLIE Pharmaceutical JSC FCF Yield % Related Terms
ENLIE Pharmaceutical JSC FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENLIE Pharmaceutical JSC FCF Yield % Chart
ENLIE Pharmaceutical JSC Annual Data
Trend
FCF Yield %
ENLIE Pharmaceutical JSC Semi-Annual Data
FCF Yield %
HSTC:BCP vs : FCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, ENLIE Pharmaceutical JSC's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ENLIE Pharmaceutical JSC FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, ENLIE Pharmaceutical JSC's FCF Yield % distribution charts can be found below:
* The bar in red indicates where ENLIE Pharmaceutical JSC's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ENLIE Pharmaceutical JSC (HSTC:BCP) has a FCF Yield % of 0.00 as of Jul. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on ENLIE Pharmaceutical JSC and its competitors. According to the industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 1006 companies in the Drug Manufacturers industry.
Is ENLIE Pharmaceutical JSC's FCF Yield % too high?
ENLIE Pharmaceutical JSC's current FCF Yield % is 0.00. Based on the distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 1006 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, ENLIE Pharmaceutical JSC has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does ENLIE Pharmaceutical JSC's FCF Yield % compare to ?
According to the Drug Manufacturers industry distribution chart, ENLIE Pharmaceutical JSC ranks #999999 out of 1006 companies for FCF Yield %. This places ENLIE Pharmaceutical JSC in the lower half of its industry. The industry median FCF Yield % is 0.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.75, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on ENLIE Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ENLIE Pharmaceutical JSC's current FCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ENLIE Pharmaceutical JSC stock overvalued right now?
ENLIE Pharmaceutical JSC (HSTC:BCP) has a current FCF Yield % of 0.00. The current FCF Yield % is 0.00. ENLIE Pharmaceutical JSC's overall GF Score™ is 25/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For ENLIE Pharmaceutical JSC (HSTC:BCP), the current FCF Yield % is 0.00 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ENLIE Pharmaceutical JSC is engaged in the production and trading of pharmaceuticals, medical supplies, cosmetics, foods, and functional foods. It is also engaged in the wholesale of other installation materials and equipment in the construction.
25GF Score
Get the complete analysis for HSTC:BCP
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:BCP has been successfully added to your 
